JPMorgan analyst Robbie Marcus downgraded Treace Medical Concepts Inc (NASDAQ: TMCI) from Overweight to Neutral with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades

Morgan Stanley Downgrades Treace Medical Concepts Inc (TMCI) to EqualweightMay 8, 2024 9:30 AM Truist Securities Downgrades Treace Medical Concepts Inc (TMCI) to HoldMay 8, 2024 6:45 AM Stifel Downgrades Treace Medical Concepts Inc (TMCI) to HoldMay 8, 2024 6:03 AM BTIG Downgrades Treace Medical Concepts Inc (TMCI) to NeutralMay 8, 2024 5:26 AM Treace Medical Concepts, Inc. (TMCI) Misses Q1 EPS by 3c, Beats on Revenue; Lowers FY24 Revenue GuidanceMay 7, 2024 4:25 PM Form 10-Q TREACE MEDICAL CONCEPTS, For: Mar 31May 7, 2024 4:11 PM Form 8-K TREACE MEDICAL CONCEPTS, For: May 07May 7, 2024 4:09 PM Treace Medical Concepts Reports First Quarter 2024 Financial ResultsMay 7, 2024 4:05 PM